SCHEMBL5609202

SCHEMBL5609202

COc1ccc(CCCC[S])cc1

nearest known ligand 0.60

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CALM1 P0DP23 1/20 0.60
IGF1R P08069 1/20 0.58
ALOX15 P16050 1/20 0.58
TAAR1 Q96RJ0 1/20 0.55
TDP1 Q9NUW8 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
MAOB P27338 2/20 0.50
ALOX5 P09917 1/20 0.50
SIGMAR1 Q99720 1/20 0.48
AOC3 Q16853 1/20 0.48
IDO1 P14902 1/20 0.48
ALDH1A1 P00352 1/20 0.47
POLB P06746 1/20 0.47
F2RL1 P55085 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5610091 0.94 CALM1 (0.62) CALM1IGF1RALOX15TAAR1TDP1
SCHEMBL4254058 0.89 CALM1 (0.72) CALM1IGF1RALOX15TAAR1TDP1
SCHEMBL11007798 0.87 CALM1 (0.69) CALM1IGF1RALOX15TAAR1TDP1
SCHEMBL10571532 0.87 CALM1 (0.69) CALM1IGF1RALOX15TAAR1TDP1
SCHEMBL17400406 0.87 CALM1 (0.69) CALM1IGF1RALOX15TAAR1TDP1
SCHEMBL9509173 0.87 CALM1 (0.69) CALM1IGF1RALOX15TAAR1TDP1
SCHEMBL5609660 0.85 TAAR1 (0.61) CALM1TAAR1MAOBSIGMAR1AOC3
SCHEMBL244070 0.84 CALM1 (0.79) CALM1IGF1RALOX15TAAR1TDP1
SCHEMBL10569081 0.83 MAOB (0.70) CALM1IGF1RALOX15TAAR1TDP1
SCHEMBL10568997 0.81 CASP3 (0.63) CALM1IGF1RALOX15TAAR1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7199139-B2 Medicinal compositions containing diuretic and insulin resistance-improving agent SANKYO COMPANY, LIMITED (JP) 2007-04-03 US disclosed
EP-1354602-B1 MEDICINAL COMPOSITIONS CONTAINING DIURETIC AND INSULIN RESISTANCE-IMPROVING AGENT SANKYO CO (JP) 2006-10-04 EP disclosed
EP-1695716-A2 Medicinal compositions containing diuretics and insulin sensitizers Sankyo Company, Limited (JP) 2006-08-30 EP disclosed
US-20050288339-A1 Medicinal compositions containing diuretic and insulin resistance-improving agent SANKYO COMPANY, LIMITED (JP) 2005-12-29 US disclosed
US-20040053974-A1 Medicinal compositions containing diuretic and insulin resistance-improving agent SANKYO COMPANY, LIMITED (JP) 2004-03-18 US disclosed
EP-1354602-A1 MEDICINAL COMPOSITIONS CONTAINING DIURETIC AND INSULIN RESISTANCE-IMPROVING AGENT Sankyo Company, Limited (JP) 2003-10-22 EP disclosed
EP-0916651-B1 PHENYLALKYLCARBOXYLIC ACID DERIVATIVES SANKYO CO (JP) 2003-10-15 EP disclosed
US-6103907-A ALDOSE REDUCTASE INHIBITING ANTIDIABETIC AGENT SANKYO COMPANY, LIMITED (JP) 2000-08-15 US disclosed
EP-0916651-A1 PHENYLALKYLCARBOXYLIC ACID DERIVATIVES Sankyo Company, Limited (JP) 1999-05-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040053974-A1 Medicinal compositions containing diuretic and insulin resistance-improving agent GPR119, INSR, IRS1 CALM1 1156/4885IGF1R 9/4885ALOX15 1884/4885
US-20050288339-A1 Medicinal compositions containing diuretic and insulin resistance-improving agent GPR119, INSR, IRS1 CALM1 1156/4885IGF1R 9/4885ALOX15 1884/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.